Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 93 of 113, showing 5 Applications out of 564 total, starting on record 461, ending on 465

# Protocol No Study Title Investigator(s) & Site(s)

461.

ECCT/16/09/03   Effect of Schistosoma mansoni infection on incidence of Plasmodium falciparum malaria among 1-5 year old children in western Kenya.
    Effect of Schistosoma mansoni infection on incidence of Plasmodium falciparum malaria among 1-5 year old children in western Kenya.   
Principal Investigator(s)
1. Dr.Pauline NM Mwinzi
Site(s) in Kenya
KEMRI CGHR
 
View

462.

ECCT/21/06/15   Therapeutic Efficacy Study
    Efficacy of Artemether Lumefantrine (AL) and Dihydroartemisinin-Piperaquine (DHP) for the treatment of uncomplicated Plasmodium falciparum malaria in Siaya and Bungoma counties, Kenya.   
Principal Investigator(s)
1. Dr. Sarah-Blythe Ballard
2. Dr. Willis Akhwale
3. Dr. Grace Ikahu
4. Dr. George Githuka
5. Dr. Dickson Mtungu Mwakangalu
6. Dr. Elvis Omondi Oyugi
7. Hellen Gatakaa
8. Regina Jepkosgei Kandie
9. Dr. Fredrick Ouma Odhiambo
Site(s) in Kenya
1. Mahonge Health Center (Bung\'oma county)
2. Kaluo Health Center (Siaya county)
 
View

463.

ECCT/25/08/08   PROPS Trial
    Efficacy of probiotic supplementation in preterm and small for gestational age infants. A multi-centre, placebo-controlled, individually-randomised trial   (Probiotics in preterm and small for gestational age infants, PROPS trial)   
Principal Investigator(s)
1. Maureen Muchela
Site(s) in Kenya
1. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
2. Homabay County Referral Hospital (Homa Bay county)
3. Kisii Teaching and Referral Hospital (Kisii county)
4. Migori County Referral Hospital (Migori county)
 
View

464.

ECCT/11/12/02   VAC 46 Trial
    Efficacy Study of ChAd63-MVA ME-TRAP prime-boost Vaccination against Plasmodium falciparum infection.   
Principal Investigator(s)
1. Caroline Amolo Ogwang
Site(s) in Kenya
Junju Dispensary
 
View

465.

ECCT/23/01/05   IMPALA Study
    Efficacy, Safety and Effectiveness of Injectable Cabotegravir/Rilpivirine in Improving HIV-1 Control in Sub-Saharan Africa: A Pragmatic Phase 3b Open-Label Randomized Controlled Trial   
Principal Investigator(s)
1. Loice Achieng Ombajo
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
 
View